Literature DB >> 30431096

C1QTNF6 is overexpressed in gastric carcinoma and contributes to the proliferation and migration of gastric carcinoma cells.

Hai-Xia Qu1, Lin Cui2, Xin-Ying Meng2, Zhi-Jie Wang3, Yan-Xin Cui2, Yun-Peng Yu2, Dong Wang3, Xiang-Jun Jiang1.   

Abstract

In the present study, proteins differentially expressed between gastric cancer tissue and para‑tumoral normal gastric tissues were screened, and the function of the highly expressed protein C1QTNF6 in gastric carcinoma was investigated. The differential expression of mRNAs extracted from the tumor and adjacent tissues was analyzed using GeneChip assay. An AGS si‑C1QTNF6 cell line was constructed using shRNA‑C1QTNF6 lentivirus. The cell invasion and migration ability of C1QTNF6‑knockdown cells were determined by Transwell chamber migration and wound healing assays, respectively. The effects of C1QTNF6 on AGS cell cycle distribution and apoptosis were detected using a FACScan flow cytometer. The results demonstrated that the expression of 109 genes was increased and the expression of 129 was decreased in tumor tissues. Among these genes, the C1QTNF6 gene was highly expressed in tumor tissues and the AGS7901 cell line. C1QTNF6‑knockdown decreased the cell growth, and the proliferative and migration ability, as well as increasing the apoptosis of gastric carcinoma cells. In addition, the number of AGS cells in the G2/M phase was significantly increased after 5 days of C1QTNF6‑shRNA lentivirus infection. The results of the present study indicated that C1QTNF6 serves an important role in the development of gastric carcinoma. C1QTNF6 is involved in promoting the proliferation and migration, and in reducing the apoptosis of gastric carcinoma cells. These results provided a potential therapeutic target for the treatment of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30431096     DOI: 10.3892/ijmm.2018.3978

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  11 in total

1.  Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers.

Authors:  Iori Motoo; Sohachi Nanjo; Takayuki Ando; Satoshi Yamashita; Toshikazu Ushijima; Ichiro Yasuda
Journal:  Gastric Cancer       Date:  2021-09-23       Impact factor: 7.370

2.  Genes and pathways monotonically dysregulated during progression from normal through leukoplakia to gingivo-buccal oral cancer.

Authors:  Debodipta Das; Arindam Maitra; Chinmay K Panda; Sandip Ghose; Bidyut Roy; Rajiv Sarin; Partha P Majumder
Journal:  NPJ Genom Med       Date:  2021-05-12       Impact factor: 8.617

3.  C1QTNF6 regulates cell proliferation and apoptosis of NSCLC in vitro and in vivo.

Authors:  Wei Zhang; Ganzhu Feng
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

4.  Anti-fibrotic properties of an adiponectin paralog protein, C1q/TNF-related protein 6 (CTRP6), in diffuse gastric adenocarcinoma.

Authors:  Yoshinori Iwata; Itaru Yasufuku; Chiemi Saigo; Yusuke Kito; Tamotsu Takeuchi; Kazuhiro Yoshida
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

5.  Obesity-associated up-regulation of lipocalin 2 protects gastric mucosa cells from apoptotic cell death by reducing endoplasmic reticulum stress.

Authors:  Xin Wen; Bin Su; Mingming Gao; Jiaqi Chen; Donglei Zhou; Hui You; Nannan Li; Shuaikang Chang; Xiaoyun Cheng; Chunhua Qian; Jingyang Gao; Peng Yang; Shen Qu; Le Bu
Journal:  Cell Death Dis       Date:  2021-02-26       Impact factor: 8.469

6.  C1QTNF6 promotes oral squamous cell carcinoma by enhancing proliferation and inhibiting apoptosis.

Authors:  Xiaobin Song; Longjie Li; Liang Shi; Xinyu Liu; Xun Qu; Fengcai Wei; Ketao Wang
Journal:  Cancer Cell Int       Date:  2021-12-14       Impact factor: 5.722

7.  C1QTNF6 is a Prognostic Biomarker and Related to Immune Infiltration and Drug Sensitivity: A Pan-Cancer Analysis.

Authors:  Wei Liu; Jian Zhang; Tao Xie; Xiaoting Huang; Baiyao Wang; Yunhong Tian; Yawei Yuan
Journal:  Front Pharmacol       Date:  2022-03-23       Impact factor: 5.810

8.  A New Hypoxia-Related Prognostic Risk Score (HPRS) Model Was Developed to Indicate Prognosis and Response to Immunotherapy for Lung Adenocarcinoma.

Authors:  Xiahui Yang; Minchao Liang; Zhiqi Yu; Jiaquan Fan
Journal:  J Oncol       Date:  2022-07-30       Impact factor: 4.501

9.  Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer.

Authors:  Liumeng Jian; Guangda Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-19       Impact factor: 3.168

10.  C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients.

Authors:  Xin Zhu; Hang Tong; Shun Gao; Hubin Yin; Gongmin Zhu; Xinyuan Li; Weiyang He; Xin Gou
Journal:  Biomed Res Int       Date:  2020-10-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.